A more dynamic, data-driven approach is redefining what “good” looks like in copay support.
Brian Laird
Advertisement
Brian Laird is president of patient services at EVERSANA.
Articles by Brian Laird
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: AbbVie and Haisco Enter $745 Million Licensing Agreement
2
How Are Regulatory Factors Impacting Biosimilars
3
Travere Therapeutics’ Filspari Receives Full FDA Approval
4
How Serious is the Biosimilar Void?
5